文献速递胃肠动力与功能性疾病

数字化肠道导向催眠疗法与肌肉放松疗法治疗肠易激综合征的随机平行组研究

A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-06-28

该随机对照试验比较了数字化肠道导向催眠疗法(GDH)与数字化肌肉放松(MR)治疗成人肠易激综合征(IBS)的安全性和有效性。在378例随机患者中,362例纳入疗效分析。GDH组与MR组达到主要终点(腹痛应答)的比例相似(30.4% vs 27.1%,P=.5352),无显著差异。在治疗最后4周及整个治疗期间,GDH组的腹痛应答率显著高于MR组。

要点

  • GDH组与MR组主要终点腹痛应答率分别为30.4%和27.1%,无显著差异(P=.5352)。
  • 治疗最后4周GDH组腹痛应答率30.9%显著高于MR组21.5%(P=.0232)。
  • 整个治疗期间GDH组腹痛应答率29.3%显著高于MR组18.8%(P=.0254)。

核心结论

  • 数字化GDH项目治疗改善了IBS患者的腹痛和粪便症状,支持该干预作为IBS整合照护的一部分。

研究设计与样本

  • 随机对照试验,比较数字化GDH(Regulora)与数字化MR(通过智能手机或平板电脑应用程序获取)治疗成人IBS。
  • 经过4周导入期后,患者随机接受12周治疗。
  • 378例随机患者中,362例接受治疗并纳入疗效分析。
  • 主要终点为腹痛应答,定义为治疗后4周内平均每日腹痛强度较基线降低≥30%。

主要发现

  • GDH组30.4%与MR组27.1%达到主要终点,组间无显著差异(P=.5352)。
  • 治疗最后4周,GDH组腹痛应答率30.9%显著高于MR组21.5%(P=.0232)。
  • 整个治疗期间,GDH组腹痛应答率29.3%显著高于MR组18.8%(P=.0254)。
  • 腹痛、粪便稠度和排便频率的改善在不同IBS亚型中一致。
  • 无患者经历严重不良事件或因不良事件导致研究中止。

关键数值与推荐

  • 主要终点腹痛应答:GDH组30.4% vs MR组27.1%(P=.5352)。
  • 治疗最后4周腹痛应答:GDH组30.9% vs MR组21.5%(P=.0232)。
  • 整个治疗期间腹痛应答:GDH组29.3% vs MR组18.8%(P=.0254)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Gut-directed hypnotherapy (GDH) is effective for treating irritable bowel syndrome (IBS), but access limits its widespread use. We report the first randomized controlled trial comparing the safety and efficacy of a self-administered, digital GDH treatment program with that of digital muscle relaxation (MR) in adults with IBS. METHODS: After a 4-week run-in period, patients were randomized to 12 weeks of treatment with digital GDH (Regulora), or digital MR accessed via a mobile app on a smartphone or tablet. The primary endpoint was abdominal pain response, defined as ≥30% reduction from baseline in average daily abdominal pain intensity in the 4 weeks following treatment. Key secondary outcomes included mean change from baseline in abdominal pain, stool consistency, and stool frequency. RESULTS: Of 378 randomized patients, 362 were treated and included in the efficacy analysis. A similar proportion of the GDH (30.4%) and MR (27.1%) groups met the primary endpoint, with no significant difference between the groups (P = .5352). Significantly more patients treated with GDH than MR were abdominal pain responders during the last 4 weeks of treatment (30.9% vs 21.5%; P = .0232) and over the entire treatment period (29.3% vs 18.8%; P = .0254). Improvements in abdominal pain, stool consistency, and stool frequency were consistent across IBS subtypes. No patients experienced serious adverse events or adverse events leading to study discontinuation. CONCLUSIONS: Treatment with a digital GDH program led to an improvement in abdominal pain and stool symptoms in patients with IBS, supporting a role for this intervention as part of integrated care for IBS. CLINICALTRIALS: gov identifier NCT04133519.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Berry SK, Berry R, Recker D, et al. A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2023. PMID: 37391055. doi:10.1016/j.cgh.2023.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。